RxDoctor Payments DataLook up a doctor →

NINLARO: payments to doctors

Payments that named NINLARO as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$5.9M
Providers
7,929
Transactions
23,798
Average per transaction
$247

The per-transaction average — $247 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,929 providers the average total is $741, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Takeda Pharmaceuticals U.S.A., Inc.$5,871,17799.9%
Takeda Pharmaceutical Company, Limited$6,4000.1%
← All drugs & devices